Abstract: Slide Presentations |

No Role for Azithromycin Therapy in BOS in Lung Transplant Recipients FREE TO VIEW

David Shitrit, MD*; Milton Saute, MD; Gidon Sahar, MD; Ilana Bakal, MD; Mordechai R. Kramer, MD, FCCP
Author and Funding Information

Rabin Medical Center, Jerusalem, Israel


Chest. 2004;126(4_MeetingAbstracts):712S. doi:10.1378/chest.126.4_MeetingAbstracts.712S
Text Size: A A A
Published online


PURPOSE:  Long-term survival after lung transplantation is limited by the development of bronchiolitis obliterans syndrome (BOS). Recently, a pilot study reported an improvement in lung function in 5 of 6 lung transplant recipients with BOS treated with oral azithromycin. However, there are no available data on the long-term effect of macrolides in BOS.

METHODS:  The study sample consisted of 11 lung transplant recipients with BOS who were treated with oral azthromycin 250 mg three times per week for a mean duration of 10 months. Spirometry was performed at each follow-up visit (every 4 weeks) to evaluate forced expiratory volume in 1 sec (FEV1). Follow-up began with onset of treatment and continued to the time of article preparation.

RESULTS:  Mean FEV1 measured 40±9% at initiation of azithromycin treatment, 39±10% after one month, and 39±12%, 38±10%, and 38±10% after 4, 7, and 10 months, respectively (p=NS for all data). FEV1 improved after 4 months in 2 patients, although both returned to their basal lung function on long-term follow-up. No significant decline in lung function was noted in the 2 patients with gastroesophageal reflux disease compared to the other patients, or in the 9 patients with Pseudomonas colonization.

CONCLUSION:  Findings of the present open pilot study indicate that long-term azithromycin therapy has no effect in lung transplant recipients with BOS.

CLINICAL IMPLICATIONS:  Long-term Azithromycin Therapy may be assumed to play no Effective Role in Lung Transplant Recipients.

DISCLOSURE:  D. Shitrit, None.

Monday, October 25, 2004

10:30 AM- 12:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543